Chicago Rivet & Machine Co.
AAMEX:CVRRecent
price
P/E
ratio
div
yld
0.82%
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Chicago Rivet & Machine Co. manufactures and sells cold-formed fasteners, riveting machinery, and automated assembly systems for the industrial fastener sector; its core offerings include custom cold-headed parts such as rivets, screw machine products, and precision-machined components produced through cold forming and turning technologies, alongside standard and custom mechanical, pneumatic, and hydraulic riveting equipment, assembly tools, machine parts, and integrated work cells. The company serves automotive, appliance, electrical, aerospace, medical device, and general manufacturing industries through independent sales representatives across North America, with manufacturing facilities in Tyrone, Pennsylvania, and Madison Heights, Michigan via subsidiary H & L Tool Company, Inc., an ISO/IATF 16949-certified producer of precision turned and cold-formed products; corporate headquarters are located in Warrenville, Illinois, with an automated assembly office in Pembroke, Massachusetts. Founded in 1920 and publicly listed on NYSE American (CVR) since 1930, the company maintains ISO 9001 and IATF 16949 certifications for its fastener division and reports ongoing operational enhancements, including a 91.3% gross profit increase in recent quarterly results driven by favorable product mix and efficiency gains, alongside consistent quarterly filings through November 2025 reflecting sustained focus on financial transparency and strategic stability amid market fluctuations.
Company News
NewcelX Enters into Binding Term Sheet to Divest Legacy Mazindol Portfolio (CVR), Providing for Upfront Cash, Equity Ownership and Up to $55 Million in Potential Milestone Payments
CVR Partners: Buy The Dip Ahead Of Its Coming Rebound
CVR Partners Q3 Earnings Call Highlights
CVR Energy Announces Pricing of Offering of Common Stock
CVR Energy Announces Proposed Offering of Common Stock
Marathon beats quarterly estimates, to sell two refineries to CVR Energy
CVR Partners Reports Third Quarter 2026 Results
CVR Energy Announces Transformative Transaction to Acquire 2 Refineries and Marketing Platform From Marathon Petroleum
CVR Energy nears more than $4 billion deal for Marathon refineries, WSJ reports
Carl Icahn's CVR Energy Near Over $4 Billion Deal for Marathon Refineries
CVR Energy Announces Revised Time for Third Quarter 2026 Earnings Conference Call
CVR Partners Announces Revised Time for Third Quarter 2026 Earnings Conference Call
InMed Announces CVR Distribution Record Date in Connection with Proposed Merger
CVR Partners to Release Third Quarter 2026 Earnings Results
CVR Energy to Release Third Quarter 2026 Earnings Results
Atossa Therapeutics Common Stock to Begin Trading with Stapled Contingent Value Rights After Close of Business Today
CVR Energy Should Keep Flowing Higher
Atossa Therapeutics Announces Plan to Issue Stapled CVR for Shareholders Tied to Potential Rare Pediatric Disease Priority Review Voucher
CVR Partners: Middle East Supply Shocks And Domestic Cost Advantages Make This 12%+ Yield A Compelling Buy
CVR Partners: A Boring Fertilizer Stock Benefiting From A Not-So-Boring World